Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure

por Laderach, Diego José, Compagno, Daniel
Publicado 2021

Inhibition of galectins in cancer: Biological challenges for their clinical application

por Laderach, Diego José, Compagno, Daniel
Publicado 2023

Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials

por Compagno, Daniel, Tiraboschi, Carolina, Garcia, José Daniel, Rondón, Yorfer, Corapi, Enrique, Velazquez, Carla, Laderach, Diego José
Publicado 2020

Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer

por Gentilini, Lucas Daniel, Jaworski, Felipe Martín, Tiraboschi, Carolina, Pérez, Ignacio González, Kotler, Monica Lidia, Chauchereau, Anne, Laderach, Diego Jose, Compagno, Daniel
Publicado 2017

Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome

por Tiraboschi, Carolina, Gentilini, Lucas, Velazquez, Carla, Corapi, Enrique, Jaworski, Felipe Martín, Garcia Garcia, José Daniel, Rondón, Yorfer, Chauchereau, Anne, Laderach, Diego José, Compagno, Daniel
Publicado 2020